Briefing Summary: US FDA Posts Advisory Committee Materials for Review of Proposed Cardiovascular Claims for Novo Nordisk’s Victoza Report
Briefing Summary: US FDA Posts Advisory Committee Materials for Review of Proposed Cardiovascular Claims for Novo Nordisk’s Victoza Report